Showing results (911-920 of 987) with videos related to
Sort By:
Pageof 99
EJNMMI Radiopharmacy and Chemistry|February 6, 2026
A new 68Ga-labeled dimeric FAP ligand to advance targeted PET imaging of cancerFeng Li, Chaitanya Kondam, Zhen Yang, et al.American Journal of Respiratory and Critical Care Medicine|September 1, 1996
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysisS L Johnston, P K Pattemore, G Sanderson, et al.Thorax|September 17, 2005
Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthmaP H Howarth, K S Babu, H S Arshad, et al.Allergy|July 22, 2014
Stability of phenotypes defined by physiological variables and biomarkers in adults with asthmaM Kupczyk, B Dahlén, P J Sterk, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 17, 2004
Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I StudyA Grimfeld, S T Holgate, G W Canonica, et al.The Lancet. Respiratory Medicine|November 15, 2020
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trialPhillip D Monk, Richard J Marsden, Victoria J Tear, et al.American Journal of Respiratory Cell and Molecular Biology|July 1, 1996
Phenotypic analysis of airway eosinophils and lymphocytes in a Th-2-driven murine model of pulmonary inflammationA D Watkins, C A Hatfield, S F Fidler, et al.American Journal of Respiratory and Critical Care Medicine|January 10, 2002
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialSven-Erik Dahlén, Kerstin Malmström, Ewa Nizankowska, et al.Lancet (London, England)|February 24, 2001
Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic responseS A Bryan, B J O'Connor, S Matti, et al.American Journal of Respiratory and Critical Care Medicine|June 18, 2014
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trialRatko Djukanović, Tim Harrison, Sebastian L Johnston, et al.Pageof 99